Delivery Order SPE2DB24D9105-SPE2DB25FBYUR

Award Date 6/12/25
Potential Completion Date 7/7/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,568,384,319 doses of the YF-VAX vaccine, with a total ceiling value of $1,670.13. The delivery order has an ultimate completion date of June 13, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a significant Indefinite Delivery Contract (IDC) with...
This is a $1,690.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,058,724 doses of the YF-VAX vaccine, with a completion date of June 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, running through December...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,568,579,768 doses of the YF-VAX 1 vaccine, with a ceiling value of $2,783.55 and a performance period ending on July 7, 2025. The contract is not set aside for a specific business size or socioeconomic category. DMS Pharmaceutical Group Inc. is a key supplier of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,512,925 doses of the YF-VAX vaccine, with a ceiling value of $11,269.80 and a completion date of December 10, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,568,384,321 doses of the YF-VAX vaccine, with a ceiling value of $7,237.23 and a performance period ending on June 13, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $55,671.00, is for the delivery of 4,567,998,768 doses of the YF-VAX 1 vaccine. The order has an ultimate completion date of May 8, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,342,887 doses of the YF-VAX 1 vaccine, with a total ceiling value of $1,113.42 and a period of performance through June 10, 2025. DMS Pharmaceutical Group Inc. is a critical supplier in the federal pharmaceutical supply chain, holding a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,199,564 doses of the YF-VAX 1 vaccine, with a ceiling value of $66,805.20 and a period of performance through May 28, 2025. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of 4,566,429 doses of the YF-VAX vaccine, with a total ceiling value of $11,833.29. The contract has a period of performance through November 29, 2024. DMS Pharmaceutical Group holds a larger single-award Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,126.98, is for the delivery of 4,565,563,472 doses of the YF-VAX 1 DOSE VIALS vaccine. The order has a completion date of September 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
  • SPE2DB24D9105
    Indefinite Delivery Contract
  • SPE2DB24D9105-SPE2DB25FBYUR
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,579,063 doses of the YF-VAX vaccine, with an ultimate completion date of July 7, 2025 and a ceiling value of $2,226.84. The contract has no set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.

Generated 9/11/25, 11:04 AM